In detail, in NSCLC, EGFR presents with recurrent hot-spot alterations (single nucleotide missense variant as well as small insertion/deletions) at exons 18 to 21, codifying for the tyrosine kinase domain. Here, EGFR is linked to non-small cell lung carcinoma.